Pharma Focus Asia

How Prancer RTSM® Enables Complex Studies - The Complex Study is Here to Stay

Author: Libbi Rickenbacher

Director of Strategy at 4G Clinical, has more than 15 years of experience in the field of life science, and is an e-clinical RTSM solutions subject matter expert.

Overview

Clinical researchers are becoming much more creative in how they explore possible treatments. They are leveraging more adaptive trials where phases can be combined or skipped based on positive results, or where the protocol is amended to explore new treatments or disease states within the same trial. This approach allows researchers to follow the science throughout clinical development, and not waste time and resources on what is not working. This creativity has led to an increase in clinical trial complexity, creating a cascade of considerations impacting everything from protocol design through the resulting flexible supply chain infrastructure required to support modern trials. As trial complexity continues to increase, the technology supporting them has responded with intuitive innovative solutions, significantly reducing complex study burden.

Download '.pdf' Format of the whitepaper.

Download Whitepapers
magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024